Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Porfiromycin with Radiation in Solid Tumors
NCT02209701Phase 1Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 1999
- Primary completion
- Jul 2000
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of porfiromycin in head and neck cancer (HNC) and solid tumor, sponsored by Boehringer Ingelheim. Primary endpoints: Assessment of serum concentrations of the analyte and Amount of analyte excreted in urine. Started Dec 1999; status: terminated.
02
Drugs
porfiromycin
03
Conditions
head and neck cancer (HNC)solid tumor
Beyond the preview
Go deeper on NCT02209701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209701.